OncLive - Clinical Oncology News, Cancer Expert Insights
OncLive - Clinical Oncology News, Cancer Expert Insights
Spotlight
The OncLive Insider app is live!CME Opportunities
Specialty
View MoreBreast CancerLung CancerGastrointestinal CancerGenitourinary CancersOvarian CancerProstate CancerMelanoma & Skin CancerMCLMPNCAR T-cell TherapyChronic Lymphocytic LeukemiaGynecologic OncologyHematologic OncologyImmuno-OncologyMultiple MyelomaUrothelial Cancer
News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
PartnersPublications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker ConsortiumSubscribe
  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information

© 2025 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Spotlight
  • The OncLive Insider app is live!
  • CME Opportunities
SpecialtySee All >
  • Breast Cancer
  • Lung Cancer
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Ovarian Cancer
  • Prostate Cancer
  • Melanoma & Skin Cancer
  • MCL
  • MPN
  • CAR T-cell Therapy
  • Chronic Lymphocytic Leukemia
  • Gynecologic Oncology
  • Hematologic Oncology
  • Immuno-Oncology
  • Multiple Myeloma
  • Urothelial Cancer
OncLive SOSS
  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
  • MJHLS Brand Logo

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Mark D. Pegram, MD, Stanford Cancer Center

  1. home

Articles

Impact of Recent Clinical Data on Treatment for HER2+ MBC

June 30th 2020

CDK4/6 Inhibitors for Triple-Positive Breast Cancer

June 30th 2020

SOPHIA: Margetuximab + Chemotherapy for RR HER2+ MBC

June 30th 2020

DS-8201 and Tucatinib in HER2+ Metastatic Breast Cancer

June 30th 2020

Treatment Choice for Patient Relapsing With Brain Metastases

June 30th 2020

HER2CLIMB: Brain Metastases Data

June 30th 2020

Biomarker Data After Neoadjuvant Therapy for HER2+ Breast Cancer

June 30th 2020

HER2+ Early Stage Breast Cancer With Residual Invasive Disease

June 30th 2020

KAITLIN: T-DM1/Pertuzumab After Anthracycline-Based Adjuvant Therapy

June 30th 2020

TRAIN-2: Anthracyclines in HER2+ Breast Cancer

June 30th 2020

APHINITY and ExteNET Trials for Early-Stage Breast Cancer

June 30th 2020

HER2+ Early-Stage Breast Cancer

June 30th 2020

Guidelines and Approaches to HER2 Testing for Breast Cancer

June 30th 2020